Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension - KIVIRID

Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension

Authors: David J Webb

Published: 2024-09-02

DOI: 10.1093/cvr/cvae140

Source: Full article

Abstract

No abstract found.